
Pyrilutamide (developmental code name KX-826 ) is a nonsteroidal antiandrogen (NSAA) - specifically, a selective high-affinity silent antagonist of the androgen receptor (AR) - which is under development by Suzhou Kintor Pharmaceuticals, inc., a subsidiary of Kintor Pharmaceutical Limited, for the potential method of androgenic alopecia (androgen-dependent scalp hair loss) and acne in China and the United States. As of October 2022, it is in phase 3 clinical trials for androgenic alopecia and phase 2 trials for acne.
Pyrilutamide (KX-826) is under development for the method of androgen associated alopecia and acne vulgaris. It candidate is for external use and administered through topical route. It acts by targeting androgen receptor. It was also under development for the method of whelk and diabetic foot ulcer.
| HARD CAPSULE Type: 0# 1# 2# 3# Coulor: More than 30 colours are available. Capsules have a hard shell, and either contain powders or dry ingredients. Suitable for all kinds of plant extract powder. | ||
TABLET Type: 250mg 500mg 1000mg 2000mg Professional Mould, Provide you tablets of various shapes. Tablets are a harder dosage form compared to softgels and capsules. Suitable for all kinds of plant extract powder. | ![]() | ||
![]() | SOFTGEL Softgels have a gelatin shell, surrounding a gel or liquid interior.Suitable for all kinds of animal and plant essential oils. | ||
BOTTLE Volume:60cc,120cc, 150cc, 200cc, 250cc... Customized size,color and label design are available. | ![]() | ||
![]() | SMALL BAG PACKAGE Type: 10g, 50g, 100g, 500g, 1000g, 2000g... Small bag is also a good choice for a small amount of contents packaged.Customized size,color and label design are available. |
